What are the alternatives to R-CHOP in diffuse large B-cell lymphoma?
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission therapy
Alan Burnett et al.
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy
The evolving genomic landscape of acute lymphoblastic leukemia (ALL): subtypes, genes and targets